Search details
1.
High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity.
Cell
; 179(7): 1636-1646.e15, 2019 12 12.
Article
in English
| MEDLINE | ID: mdl-31787378
2.
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.
Proc Natl Acad Sci U S A
; 121(4): e2308942121, 2024 Jan 23.
Article
in English
| MEDLINE | ID: mdl-38241441
3.
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.
PLoS Pathog
; 19(6): e1011469, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37384759
4.
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
N Engl J Med
; 384(11): 1003-1014, 2021 03 18.
Article
in English
| MEDLINE | ID: mdl-33730454
5.
Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies.
PLoS Pathog
; 18(9): e1010450, 2022 09.
Article
in English
| MEDLINE | ID: mdl-36054228
6.
Functional consequences of allotypic polymorphisms in human immunoglobulin G subclasses.
Immunogenetics
; 75(1): 1-16, 2023 02.
Article
in English
| MEDLINE | ID: mdl-35904629
7.
Single-Chain Variable Fragments of Broadly Neutralizing Antibodies Prevent HIV Cell-Cell Transmission.
J Virol
; 96(4): e0193421, 2022 02 23.
Article
in English
| MEDLINE | ID: mdl-34935437
8.
Complementary Roles of Antibody Heavy and Light Chain Somatic Hypermutation in Conferring Breadth and Potency to the HIV-1-Specific CAP256-VRC26 bNAb Lineage.
J Virol
; 96(10): e0027022, 2022 05 25.
Article
in English
| MEDLINE | ID: mdl-35510865
9.
HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies.
J Virol
; 96(14): e0032422, 2022 07 27.
Article
in English
| MEDLINE | ID: mdl-35758668
10.
Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies.
J Virol
; 96(2): e0164321, 2022 01 26.
Article
in English
| MEDLINE | ID: mdl-34730393
11.
ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.
PLoS Pathog
; 17(11): e1010046, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34788337
12.
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.
Immunity
; 41(6): 909-18, 2014 Dec 18.
Article
in English
| MEDLINE | ID: mdl-25526306
13.
The V2 loop of HIV gp120 delivers costimulatory signals to CD4+ T cells through Integrin α4ß7 and promotes cellular activation and infection.
Proc Natl Acad Sci U S A
; 117(51): 32566-32573, 2020 12 22.
Article
in English
| MEDLINE | ID: mdl-33288704
14.
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.
J Infect Dis
; 226(3): 510-520, 2022 08 26.
Article
in English
| MEDLINE | ID: mdl-35134995
15.
Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein.
Clin Infect Dis
; 72(1): 50-60, 2021 01 23.
Article
in English
| MEDLINE | ID: mdl-31900486
16.
Neutralization Breadth and Potency of Single-Chain Variable Fragments Derived from Broadly Neutralizing Antibodies Targeting Multiple Epitopes on the HIV-1 Envelope.
J Virol
; 94(2)2020 01 06.
Article
in English
| MEDLINE | ID: mdl-31619559
17.
Somatic hypermutation to counter a globally rare viral immunotype drove off-track antibodies in the CAP256-VRC26 HIV-1 V2-directed bNAb lineage.
PLoS Pathog
; 15(9): e1008005, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31479499
18.
IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody.
PLoS Pathog
; 15(12): e1008064, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31841557
19.
Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies.
Immunol Rev
; 275(1): 217-229, 2017 01.
Article
in English
| MEDLINE | ID: mdl-28133797
20.
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
PLoS Med
; 17(5): e1003117, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32442195